The Bleed Beyond Menopause: A Hidden Chapter in Women's Health - A Narrative Review
DOI:
https://doi.org/10.55544/jrasb.4.4.6Keywords:
postmenopausal bleeding, endometrial cancer, endometrial biopsy, transvaginal ultrasonography, hormonal therapyAbstract
Postmenopausal bleeding (PMB), defined as any uterine bleeding occurring after 12 months of amenorrhea, remains a key clinical concern requiring thorough assessment. Although the majority of cases arise from benign conditions such as endometrial atrophy, polyps, or hormone-related effects, PMB can also be an early indicator of gynecologic malignancies, particularly endometrial and cervical cancers. The risk of malignancy increases with advancing age and is influenced by factors such as obesity, diabetes, hypertension, and prolonged exposure to unopposed estrogen.
This narrative review discusses the diverse etiologies of PMB, outlines current diagnostic strategies, and reviews associated histopathological findings and management options. Transvaginal ultrasonography (TVUS) is the preferred initial modality, with endometrial thickness thresholds guiding further intervention. In cases where the endometrium measures ≥5 mm or presents with irregularities, additional evaluation through biopsy or hysteroscopy is warranted. Histologic patterns commonly include atrophic changes, polyps, hyperplasia, and, in a subset of patients, carcinoma.
An interdisciplinary approach—integrating gynecologists, radiologists, pathologists, and clinical pharmacists—is essential to improve diagnostic accuracy and treatment outcomes. Clinical pharmacists contribute by reviewing medication profiles, managing hormonal therapies, and supporting adherence.
In conclusion, PMB should never be dismissed as trivial. Early recognition, systematic evaluation, and coordinated care are critical to identifying underlying pathology and improving prognostic outcomes in postmenopausal women.
Downloads
References
Garg R. (2015). Postmenopausal bleeding. O&G Magazine, 54:1–4.
Vasudeva S, Baxi DA, Mishra A. (2022). A prospective study on postmenopausal bleeding-causes and its diagnosis using transvaginal ultrasound and hysteroscopy. Int J Reprod Contracept Obstet Gynecol, 11(9):2375–9.
Schindler AE, Schmidt G. (1980). Post-menopausal bleeding: a study of more than 1000 cases. Maturitas, 2:269–74.
Rubin SC. (1987). Postmenopausal bleeding: etiology, evaluation, and management. Med Clin North Am, 71(1):59–78.
van Maldegem LDRP, van der Zande JA, van Werkhoven LA, et al. (2024). Recurrent postmenopausal bleeding: pathological findings and predictive factors. Acta Obstet Gynecol Scand, 103(7):1283–91.
Begum J, Samal R. (2019). A clinicopathological evaluation of postmenopausal bleeding and its correlation with risk factors for developing endometrial hyperplasia and cancer: A hospital-based prospective study. J Mid-life Health, 10(4):179–83.
Garg R. (2015). Postmenopausal Bleeding. ResearchGate. Available at: https://www.researchgate.net/publication/286392565
Epstein E, Valentin L. (2004). Managing women with post-menopausal bleeding. Best Pract Res Clin Obstet Gynaecol, 18(1):125–43.
Smith-Bindman R, Weiss E, Feldstein V. (2004). How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Obstet Gynecol, 104(3):440–8.
Epstein E, Valentin L. (2004). Endometrial assessment in postmenopausal bleeding. Best Pract Res Clin Obstet Gynaecol, 18(1):125–43.
Wong M, Thanatsis N, et al. (2021). Risk of pre malignancy or malignancy in postmenopausal endometrial polyps: A CHAID decision tree analysis. Diagnostics, 11(6):1094. doi:10.3390/diagnostics11061094
Dubinskaya A, et al. (2022). Histopathological spectrum of postmenopausal endometrial lesions: review and update. Diagnostics, 12(9):2127. doi:10.3390/diagnostics12092127
Clarke MA, et al. (2022). Endometrial cancer presenting with postmenopausal bleeding: recent data and implications. J Clin Oncol, 40(16_suppl):e17557. doi:10.1200/JCO.2022.40.16_suppl.e17557
American College of Obstetricians and Gynecologists. (2020). ACOG Practice Bulletin No. 222: Evaluation of postmenopausal bleeding. Obstet Gynecol, 135(5):e193–e202. doi:10.1097/AOG.0000000000003771
Clark TJ, Stevenson H. (2021). Endometrial pathology in postmenopausal women with bleeding. Best Pract Res Clin Obstet Gynaecol, 78:22–32. doi:10.1016/j.bpobgyn.2021.01.006
Munro MG, Critchley HO, Fraser IS. (2011). The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril, 95(7):2204–8.
Bhatla N. (2018). Jeffcoate’s Principles of Gynaecology. 9th ed. New Delhi: Jaypee Brothers Medical Publishers.
Zito A. (2014). Postmenopausal bleeding. O & G Magazine, 16(2).
Rita D, Kumar KS, Rithesh SK. (2016). Clinicopathological study of postmenopausal bleeding. Int J Reprod Contracept Obstet Gynecol, 5(11):3671–4.
Paul P, et al. (2023). Postmenopausal bleeding: clinicopathologic study in a tertiary care centre. Int J Reprod Contracept Obstet Gynecol, 12(2):401–7.
Paul P, Devi RP, Kom TT, Nath P, Devi TN, Longjam N. (2023). Evaluation of postmenopausal bleeding: A cross-sectional study. Int J Reprod Contracept Obstet Gynecol, 12(2):401–7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. R. Subashini, Y. Sneha, C. Shifa Sidhiq Fatima, C. Rifa Sidhik Fathima, V. Sandhiya, B. Rashmi Avanticaa
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
10.55544/jrasb
editor@jrasb.com or mailtojrasb@gmail.com | 
+91-8874396939
This work is licensed under a 